Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-22-031791

Director bought 205,000 shares at an average $3.47 ($711,700)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fletcher Aaron G.L. Director 2022-05-23 Purchase +150,000 $3.52 $528,000 885,000 I: show line 1 in the form
Fletcher Aaron G.L. Director 2022-05-24 Purchase +55,000 $3.34 $183,700 940,000 I: show line 2 in the form
Open-market purchases · 205,000 sh · avg $3.47 · $711,700
Loading xslF345X03/doc4.xml…